(Q38243598)

31 August 2017

title

Nutrition and brain aging: how can we move ahead? (English)

1 reference

31 August 2017

P Barberger-Gateau

1

1 reference

31 August 2017

publication date

27 August 2014

1 reference

European Journal of Clinical Nutrition

31 August 2017

published in

1 reference

31 August 2017

volume

68

1 reference

31 August 2017

issue

11

1 reference

31 August 2017

page(s)

1245-1249

1 reference

New insights into nutrition and cognitive neuroscience

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Fish, docosahexaenoic acid and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Plasma carotenoid levels and cognitive performance in an elderly population: results of the EVA Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

B-vitamins and prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Fat intake and CNS functioning: ageing and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Omega-3 fatty acids and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Nutrition, brain aging, and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Nutrition and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta-Analysis of Randomized Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Effects of ω-3 fatty acids on cognitive performance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Omega 3 fatty acids and cognitive health in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

A short-term n-3 DPA supplementation study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Relationship between central and peripheral fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Clinical practice. Vitamin D insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Vitamin D and risk of cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Vitamin K and brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Vitamin K status and cognitive function in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Dietary patterns: a novel approach to examine the link between nutrition and cognitive function in older individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Dietary patterns and risk of dementia: the Three-City cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Habitual diets rich in dark-green vegetables are associated with an increased response to ω-3 fatty acid supplementation in Americans of African ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Neurodevelopment and neurodegeneration: are there critical stages for nutritional intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Brain β-amyloid load approaches a plateau

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Mini nutritional assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Plasma phospholipids identify antecedent memory impairment in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.177

Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis

21 January 2018

1 reference

12 December 2020

The effects of multivitamins on cognitive performance: a systematic review and meta-analysis.

1 reference

12 December 2020

Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation?

1 reference

12 December 2020

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

1 reference

12 December 2020

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial

1 reference

12 December 2020

Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial

1 reference

12 December 2020

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk

1 reference

12 December 2020

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

1 reference

12 December 2020

Identifiers

DOI

10.1038/EJCN.2014.177

1 reference

Dimensions Publication ID

31 August 2017

1024419522

0 references

1 reference